Autophagy Facilitates the Development of Breast Cancer Resistance to the Anti-HER2 Monoclonal Antibody Trastuzumab
Alejandro Vázquez‐Martín(Latvian Biomedical Research and Study Centre), Javier A. Menéndez(Institut Català d'Oncologia)
Cited by 245
Related Papers
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells
|Cell Cycle|2009|251
Olive oil's bitter principle reverses acquired autoresistance to trastuzumab (Herceptin™) in HER2-overexpressing breast cancer cells
|BMC Cancer|2007|191
Effects of gamma-linolenic acid and oleic acid on paclitaxel cytotoxicity in human breast cancer cells
|European Journal of Cancer|2001|145
Metformin Is a Direct SIRT1-Activating Compound: Computational Modeling and Experimental Validation
|Frontiers in Endocrinology|2018|122